A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multicenter, randomized, placebo‐controlled, parallel‐arm, phase 2 study to investigate the clinical efficacy, pharmacokinetics, and safety of CSL312 as prophylaxis to prevent attacks in subjects with HAE.
Epistemonikos ID: deeb6402292647d40b833fc80d7de9871cf56f09
First added on: May 21, 2024